Shareholder Alert: Ademi LLP investigates whether Stericycle, Inc. has obtained a Fair Price for its Public Shareholders


MILWAUKEE, June 3, 2024 /PRNewswire/ -- Ademi LLP is investigating Stericycle (Nasdaq: SRCL) for possible breaches of fiduciary duty and other violations of law in its transaction with Waste Management.

AdemiLogo (PRNewsfoto/Ademi LLP)

Click here to learn how to join the https://www.ademilaw.com/case/stericycle-inc or call Guri Ademi toll-free at 866-264-3995. There is no cost or obligation to you.

In the transaction, Stericycle shareholders will receive only $62.00 per share in cash, representing a total enterprise value of approximately $7.2 billion, including approximately $1.4 billion of Stericycle's net debt. The transaction agreement unreasonably limits competing transactions for Stericycle by imposing a significant penalty if Stericycle accepts a competing bid. Stericycle insiders will receive substantial benefits as part of change of control arrangements.

We are investigating the conduct of Stericycle's board of directors, and whether they are fulfilling their fiduciary duties to all shareholders.

If you own Stericycle common stock and wish to obtain additional information, please contact Guri Ademi either at gademi@ademilaw.com or toll-free: 866-264-3995, or https://www.ademilaw.com/case/stericycle-inc

We specialize in shareholder litigation involving buyouts, mergers, and individual shareholder rights throughout the country. For more information, please feel free to call us. Attorney advertising. Prior results do not guarantee similar outcomes.

Contacts

Ademi LLP
Guri Ademi
Toll Free: (866) 264-3995
Fax: (414) 482-8001

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/shareholder-alert-ademi-llp-investigates-whether-stericycle-inc-has-obtained-a-fair-price-for-its-public-shareholders-302161969.html

SOURCE Ademi LLP

Werbung

Stericycle Analysen

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Stericycle nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
DatumRatingAnalyst
11.03.19 Stericycle Outperform Barrington Research
28.12.17 Stericycle Buy Stifel, Nicolaus & Co., Inc.
10.11.17 Stericycle Outperform Barrington Research
09.11.17 Stericycle Buy Stifel, Nicolaus & Co., Inc.
09.11.17 Stericycle Underperform RBC Capital Markets